Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split

<p>SEATTLE, Sept. 22, 2023 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” or the “Company” (NASDAQ:NLTX), a biopharmaceutical company that has designed de novo protein therapeutics utilizing sophisticated computational methods, today announced that its Board of Directors (“Board”) has approved a reverse stock split of the Company’s outstanding shares of common stock at a ratio of […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/neoleukin-therapeutics-announces-1-for-5-reverse-stock-split/">Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>